Published: September 19th 2024 | Updated: November 11th 2024
T-DXd Outranks Treatment of Physicians’ Choice in QOL for HR+/HER2-Low/Ultralow MBC
Published: October 10th 2024 | Updated: November 11th 2024
FDA Approves Inavolisib Regimen for PIK3CA-mutated, HR+, HER2— Breast Cancer
Published: October 28th 2024 | Updated: November 11th 2024
Breast Cancer May Not Affect Pregnancy Outcomes
Published: October 31st 2024 | Updated: November 11th 2024
Sexual Health During Breast Cancer: ‘Just Being Heard Is Important’
Published: September 26th 2024 | Updated: November 11th 2024
Understanding the Role of an Oncology Research Nurse
Published: October 18th 2024 | Updated: November 11th 2024
Making the Decision: Bispecifics Vs. CAR T-Cell Therapy in Myeloma